Brivaracetam
Brivaracetam is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Brivaracetam; Generic name: BRIVARACETAM; Manufacturer: Apotex Corp..
| Brand name | Brivaracetam |
|---|---|
| Generic name | BRIVARACETAM |
| Manufacturer | Apotex Corp. |
| Used for | 1 INDICATIONS AND USAGE Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Adults (16 Years and Older) : The recommended starting dosage for monotherapy or adjunctive therapy is 50 mg twice daily (100 mg per day). Based on individual patient tolerability and therapeutic response, the dosage may be adjusted down to 25 mg twice daily (50 mg per day) or up to 100 mg twice daily (200 mg per day). ( 2.1 ) Pediatric Patients (1 Month to less than 16 Years) : The recommended dosage is based on body weight and is administered orally twice daily ( 2. |
| Active ingredient(s) | BRIVARACETAM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1915620d-4f37-56c2-437e-8362bb462d07 |